OTC Pharmaceuticals in the United Kingdom
| Product Code | DAT02482 |
| Publication Date | November 2010 |
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 45 |
| ISBN Number | not applicable |
OTC Pharmaceuticals in the United Kingdom
Datamonitor's OTC Pharmaceuticals in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of OTC Pharmaceuticals in the United Kingdom's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of OTC Pharmaceuticals in the United Kingdom
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by both value and volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer and/or brand
- Also features market breakdown by distribution channel
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).
For the purpose of this report Europe comprises Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Ukraine and the United Kingdom.
Contents
- Executive Summary
- Market Overview
- Market Definition
- Research Highlights
- Market Analysis
- Market Value
- Market Segmentation I
- Market Segmentation II
- Market Share
- Five Forces Analysis
- Summary
- Buyer Power
- Supplier Power
- New Entrants
- Substitutes
- Rivalry
- Leading Companies
- Reckitt Benckiser Plc
- Johnson & Johnson
- Glaxosmithkline Plc
- Market Distribution
- Market Forecasts
- Market Value Forecast
- Macroeconomic Indicators
- Appendix
- Methodology
- Industry Associations
- Related Datamonitor Research
- Disclaimer
- About Datamonitor
- Premium Reports
- Summary Reports
- Datamonitor Consulting
- List of Tables
- Table 1: United Kingdom Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Table 2: United Kingdom Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Table 3: United Kingdom Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Table 4: United Kingdom Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Table 5: Reckitt Benckiser Plc: Key Facts
- Table 6: Reckitt Benckiser Plc: Key Financials ($)
- Table 7: Reckitt Benckiser Plc: Key Financials (£)
- Table 8: Reckitt Benckiser Plc: Key Financial Ratios
- Table 9: Johnson & Johnson: Key Facts
- Table 10: Johnson & Johnson: Key Financials ($)
- Table 11: Johnson & Johnson: Key Financial Ratios
- Table 12: Glaxosmithkline Plc: Key Facts
- Table 13: Glaxosmithkline Plc: Key Financials ($)
- Table 14: Glaxosmithkline Plc: Key Financials (£)
- Table 15: Glaxosmithkline Plc: Key Financial Ratios
- Table 16: United Kingdom Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Table 17: United Kingdom Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
- Table 18: United Kingdom Size of Population (Million), 2005-09
- Table 19: United Kingdom Gdp (Constant 2000 Prices, $ Billion), 2005-09
- Table 20: United Kingdom Gdp (Current Prices, $ Billion), 2005-09
- Table 21: United Kingdom Inflation, 2005-09
- Table 22: United Kingdom Consumer Price Index (Absolute), 2005-09
- Table 23: United Kingdom Exchange Rate, 2005-09
- List of Figures
- Figure 1: United Kingdom Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Figure 2: United Kingdom Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Figure 3: United Kingdom Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Figure 4: United Kingdom Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in The United Kingdom, 2009
- Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in The United Kingdom, 2009
- Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in The United Kingdom, 2009
- Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in The United Kingdom, 2009
- Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in The United Kingdom, 2009
- Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in The United Kingdom, 2009
- Figure 11: Reckitt Benckiser Plc: Revenues & Profitability
- Figure 12: Reckitt Benckiser Plc: Assets & Liabilities
- Figure 13: Johnson & Johnson: Revenues & Profitability
- Figure 14: Johnson & Johnson: Assets & Liabilities
- Figure 15: Glaxosmithkline Plc: Revenues & Profitability
- Figure 16: Glaxosmithkline Plc: Assets & Liabilities
- Figure 17: United Kingdom Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Figure 18: United Kingdom Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
